YKYosuke Kamada

Yosuke Kamada

*This is an algorithmically generated author record based on publicly available information.

Yosuke Kamada has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Learning Curve Analysis of Single‐Incision Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair ( SILS ‐ TEP ) Among Multiple Surgeons: A Large‐Scale CUSUM Evaluation

    by Yosuke Kamada, Kumiko Akashi, Nobuhito Kubota, Akira Endo, Yoshihiro Ikeda

    Introduction: Single‐incision laparoscopic totally extraperitoneal inguinal hernia repair (SILS‐TEP) provides excellent cosmetic outcomes but is technically more demanding than conventional multi‐port TEP. Most studies on learning curves focus on single‐surgeon experiences. This study aimed to evaluate the collective learning curves of SILS‐TEP among multiple experienced gastrointestinal surgeons using cumulative sum (CUSUM) analysis. Methods: We retrospectively reviewed 1500 consecutive unilateral SILS‐TEP procedures performed by six surgeons (250 cases per surgeon) between May 2021 and December 2025. All surgeons were proficient in general laparoscopic surgery (10–33 years of experience) but were novices in SILS‐TEP. Learning curves were analyzed based on operative time using CUSUM analysis. The proficiency threshold was identified, and perioperative outcomes were compared between the learning phase (Phase 1) and the experienced phase (Phase 2). Results: CUSUM analysis identified a mean proficiency threshold of 95 cases (range: 63–147 cases) across all surgeons. The median operative time significantly decreased from 81 min in Phase 1 to 66 min in Phase 2 ( p < 0.0001). While recurrence (0.067%) and overall complication (1.67%) rates remained stable, the incidence of peritoneal injury was significantly lower in Phase 2 compared to Phase 1 ( p = 0.0004). Conclusion: The learning curve for SILS‐TEP stabilized at an institutional mean of 95 cases under a structured mentoring program. However, individual proficiency thresholds varied notably, ranging from 63 to 147 cases. These findings suggest that while 95 cases serve as a useful institutional benchmark, training programs should remain flexible to accommodate individual surgical learning paces to ensure maximum safety.

  • Open Access

    Laparoscopic splenectomy for polysplenia with splenic torsion: a case report

    by Hidemasa Kubo, Nobuki Yamaoka, Mizuki Tamai, Hajime Kamiya, Yosuke Kamada, Tomoyuki Nagata, Ken-Ichiro Fukuda, Eigo Otsuji

    BackgroundPolysplenia refers to the presence of two or more equal-sized spleens. Very rarely, one of the multiple spleens may develop torsion and infarction.Case presentationA 21-year-old woman presented with left upper quadrant pain, the cause of which could not be diagnosed. She returned to our hospital, 2days later, without any pain improvement. Enhanced computed tomography showed splenic infarction and polysplenia. Initially, we could not identify the cause of the infarction and started conservative therapy, which did not result in any improvement. Hence, we performed a splenectomy, after securing informed consent. Because the patient was a young woman, we opted for a laparoscopic approach. During surgery, we identified the cause of the infarction as spleen pedicle torsion; the infarcted spleen was excised using an automated suturing device. We completed the laparoscopic surgery without converting it to an open laparotomy, and the patient was discharged 4days later. This was a rare case of polysplenia with splenic torsion.ConclusionLaparoscopic splenectomy is minimally invasive and has cosmetic advantages. Thus, this approach may be considered as a treatment option for this condition.


  • Open Access

    Intraoperative 5-aminolevulinic acid-mediated photodynamic diagnosis of gallbladder cancer: A case report

    by Yosuke Kamada, Yasutoshi Murayama, Tomohiro Arita, Toshiyuki Kosuga, Hirotaka Konishi, Ryo Morimura, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Hisashi Ikoma, et al.


    • 1 May 2016
      • Vol. 36  (5) , 2445-50

    Urinary 5-Aminolevulinic Acid Concentrations as a Potential Tumor Marker for Colorectal Cancer Screening and Recurrence.

    by Yosuke Kamada, Yasutoshi Murayama, Urara Ota, Kiwamu Takahashi, Tomohiro Arita, Toshiyuki Kosuga, Hirotaka Konishi, Ryo Morimura, Shuhei Komatsu, Atsushi Shiozaki, et al.

    Tumor biomarkers, such as carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9), are used to screen and monitor tumor recurrence in patients with colorectal cancer (CRC). 5-Aminolevulinic acid (5-ALA) is used in photodynamic diagnosis and therapy. Porphyrins produced by tumor cells are excreted in the urine after 5-ALA administration. In this study, we evaluated the use of porphyrins as novel tumor markers in urine samples from patients with CRC. Porphyrin metabolite concentrations were measured in urine samples of 33 patients with CRC, 16 patients with benign disease and 8 healthy adults, after 5-ALA administration. The porphyrin metabolite concentrations were significantly increased in the CRC group compared to the control group, while in CRC patients, the porphyrin metabolite concentrations in urine were significantly decreased after surgery. These results suggest that the measurement of porphyrin metabolites in urine may potentially serve as a new screening and recurrence marker for CRC.


    • 1 November 2014
      • Vol. 41  (12) , 1608-10

    [Radiosensitizing effect of 5-aminolevulinic acid (5-ALA ) in Colon cancer].

    by Yosuke Kamada, Yasutoshi Murayama, Kyoichi Harada, Masumi Nishimura, Yutaka Kondo, Hirotaka Konishi, Ryo Morimura, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, et al.

    5-aminolevulinic acid (5-ALA) is widely used in clinical practice because it shows tumor-selective accumulation of protoporphyrin IX, a fluorescent substance and a metabolite of 5-ALA. In addition, some studies have reported that 5-ALA increases the radiation sensitivity of glioma and melanoma. In this study, we investigated the radiosensitization effect of 5-ALA on colon cancer. Mice implanted with the human colon cancer cell line HT29 were administered 5-ALA and subsequently X-ray irradiated. These mice were compared with those not administered 5-ALA. Following multiple irradiations, the tumor volume of the 5-ALA group was significantly lower than that of the non-5-ALA group (day 5: p value=0.0489, day 8: p value= 0.0318, day 12: p value=0.0394). Tumor growth was inhibited by multiple irradiations in the 5-ALA group compared with the non-5-ALA group. These results suggest that 5-ALA also exhibits a radiosensitization effect on colon cancer.


    • 1 November 2012
      • Vol. 39  (12) , 2213-5

    [A case of advanced colon cancer resected successfully after neoadjuvant chemotherapy].

    by Yosuke Kamada, Masayoshi Nakanishi, Yasutoshi Murayama, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Hisashi Ikoma, Akio Kimura, Daisuke Ichikawa, Kazuma Okamoto, et al.

    This case concerns a 54-year-old male patient who had been identified as having a type 2 tumor in the cecum, which subsequent pathologic examination revealed to be an adenocarcinoma. The results of a computed tomography (CT) scan suggested that the tumor had directly invaded the right iliopsoas. Neoadjuvant chemotherapy was performed to avoid a non-curative resection. CT and positron-emission tomography(PET) findings after the 6th course of chemotherapy revealed a significant reduction in tumor size, at which point a right hemicolectomy with D3 nodal dissection was performed. The changes from neoadjuvant chemotherapy were judged to be Grade 1a. The patient was recurrence-free at his 14- months follow-up examination. Neoadjuvant chemotherapy with a drug that targets a specific molecule is a useful treatment for patients with an unresectable primary cancer.